The role of activation-induced deaminase in Lupus Nephritis

References

• Koffler D., Schur P. H., Kunkel H. G.. Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 1967; 126:607–624.
   PubMed Web of Science ®Google Scholar
• Koffler D., Agnello V., Kimkel H. G.. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am. J. Pathol. 1974; 74:109–124.
   PubMed Web of Science ®Google Scholar
• Lloyd W., Schur P. H.. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore). 1981; 60:208–217.
   PubMed Web of Science ®Google Scholar
• van Es J. H., Gmelig Meyling F. H., van de Akker W. R., . Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J. Exp. Med. 1991; 173:461–470.
   PubMed Web of Science ®Google Scholar
• Winkler T. H., Fehr H., Kalden J. R.. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur. J. Immunol. 1992; 22:1719–1728.
   PubMed Web of Science ®Google Scholar
• Wellmann U., Letz M., Herrmann M., . The evolution of human anti-double-stranded DNA autoantibodies. Proc. Natl. Acad. Sci. USA. 2005; 102:9258–9263.
   PubMed Web of Science ®Google Scholar
• Chen C., Nagy Z., Radic M. Z., . The site and stage of anti-DNA B-cell deletion. Nature. 1995; 373:252–255.
   PubMed Web of Science ®Google Scholar
• Culton D. A., O'Conner B. P., Conway K. L., . Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 2006; 176:790–802.
   PubMed Web of Science ®Google Scholar
• Li Y., Li H., Ni D., Weigert M.. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 2002; 196:1543–1552.
   PubMedGoogle Scholar
• Mandik-Nayak L., Seo S. J., Sokol C., . MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 1999; 189:1799–1814.
   PubMedGoogle Scholar
• Bao L., Osawe I., Haas M., Quigg R. J.. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J. Immunol. 2005; 175:1947–1955.
   PubMedGoogle Scholar
• Pickering M. C., Botto M., Taylor P. R., Lachmann P. J., Walport M. J.. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000; 76:227–324.
   PubMed Web of Science ®Google Scholar
• Watanabe H., Garnier G., Circolo A., . Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 2000; 164:786–794.
   Web of Science ®Google Scholar
• Pascual V., Banchereau J., Palucka A. K.. The central role of dendritic cells and interferon-alpha in SLE. Curr. Opin. Rheumatol. 2003; 15:548–556.
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N., Lawson B. R.. Tumour necrosis factor and other cytokines in murine lupus. Ann. Rheum. Dis. 1999; 58 Suppl 1:I49–I55.
   Google Scholar
• Chan O. T., Hannum L. G., Haberman A. M., Madaio M. P., Shlomchik M. J.. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 1999; 189:1639–1648.
   PubMed Web of Science ®Google Scholar
• Muramatsu M., Kinoshita K., Fagarasan S., . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102:553–563.
   PubMed Web of Science ®Google Scholar
• Revy P., Muto T., Levy Y., . Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000; 102:565–575.
   PubMed Web of Science ®Google Scholar
• Eisen H. N., Siskind G. W.. Variations in affinities of antibodies during the immune response. Biochemistry. 1964; 3:9961008.
   Google Scholar
• Klinman N. R.. The mechanism of antigenic stimulation of primary and secondary clonal precursor cells. J. Exp. Med. 1972; 136:241–260.
   PubMed Web of Science ®Google Scholar
• Weigert M. G., Cesari I. M., Yonkovich S. J., Cohn M.. Variability in the lambda light chain sequences of mouse antibody. Nature. 1970; 228:1045–1047.
   PubMed Web of Science ®Google Scholar
• Crews S., Griffin J., Huang H., Calame K., Hood L.. A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell. 1981; 25:59–66.
   PubMed Web of Science ®Google Scholar
• Berek C., Berger A., Apel M.. Maturation of the immune response in germinal centers. Cell. 1991; 67:1121–1129.
   PubMed Web of Science ®Google Scholar
• Chaudhuri J., Alt F. W.. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 2004; 4:541–552.
   PubMed Web of Science ®Google Scholar
• Kataoka T., Miyata T., Honjo T.. Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. Cell. 1981; 23:357–368.
   PubMedGoogle Scholar
• Theofilopoulos A. N., Dixon F. J.. Murine models of systemic lupus erythematosus. Adv. Immunol. 1985; 37:269–390.
   PubMed Web of Science ®Google Scholar
• Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., . Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978; 148:1198–1215.
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S.. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992; 356:314–317.
   PubMed Web of Science ®Google Scholar
• Jiang C., Foley J., Clayton N., . Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 2007; 178:7422–7431.
   PubMed Web of Science ®Google Scholar
• Jiang C., Zhao M. L., Diaz M.. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology. 2009; 126:102–113.
   PubMed Web of Science ®Google Scholar
• Zan H., Zhang J., Ardeshna S., . Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination. Autoimmunity. 2009; 42:89–103.
   PubMed Web of Science ®Google Scholar
• Boes M., Schmidt T., Linkemann K.. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA. 2000; 97:1184–1189.
   PubMed Web of Science ®Google Scholar
• Melamed D., Miri E., Leider N., Nemazee D.. Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice. J. Immunol. 2000; 165:4353–4358.
   PubMed Web of Science ®Google Scholar
• Forger F., Matthias T., Oppermann M., Becker H., Helmke K.. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus. 2004; 13:36–44.
   PubMed Web of Science ®Google Scholar
• Jiang C., Zhao M. L., Scearce R. M., Diaz M.. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum. 2011; 63:1086–1096.
   PubMed Web of Science ®Google Scholar
• Jiang C., Zhao M. L., Waters K. M., Diaz M.. Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity. Autoimmunity. 2012; 45:440–448.
   PubMed Web of Science ®Google Scholar
• Guo W., Smith D., Aviszus K., . Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J. Exp. Med. 2010; 207:2225–2237.
   PubMed Web of Science ®Google Scholar
• Sims G. P., Shiono H., Willcox N., Stott D. I.. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 2001; 167:1935–1944.
   PubMed Web of Science ®Google Scholar
• Stott D. I., Hiepe F., Hummel M., Steinhauser G., Berek C.. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome. J. Clin. Invest. 1998; 102:938–946.
   Google Scholar
• Kim H. J., Berek C.. B cells in rheumatoid arthritis. Arthritis Res. 2000; 2:126–131.
   PubMedGoogle Scholar
• Gronwall C., Vas J., Silverman G. J.. Protective roles of natural IgM antibodies. Front Immunol. 2012; 3:66.
   PubMed Web of Science ®Google Scholar
• Chong B. F., Tseng L. C., Lee T., . IgG and IgM autoantibody differences in discoid and systemic lupus patients. J. Invest. Dermatol. Epub ahead of print. 2012.
   Google Scholar
• Quartier P., Bustamante J., Sanal O., . Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin. Immunol. 2004; 110:22–29.
   PubMed Web of Science ®Google Scholar
• Kuraoka M., Holl T. M., Liao D., . Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc. Natl. Acad. Sci. USA. 2011; 108:11560–11565.
   PubMed Web of Science ®Google Scholar
• Muramatsu M., Sankaranand V. S., Anant S., . Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999; 274:18470–18476.
   PubMed Web of Science ®Google Scholar
• Crouch E. E., Li Z., Takizawa M., . Regulation of AID expression in the immune response. J. Exp. Med. 2007; 204:1145–1156.
   PubMed Web of Science ®Google Scholar
• Muto T., Muramatsu M., Taniwaki M., Kinoshita K., Honjo T.. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics. 2000; 68:85–88.
   PubMed Web of Science ®Google Scholar
• Arkwright P. D., Abinun M., Cant A. J.. Autoimmunity in human primary immunodeficiency diseases. Blood. 2002; 99:2694–2702.
   PubMed Web of Science ®Google Scholar
• Patiroglu T., Gungor H. E., Unal E.. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol. Immunol. Hung. 2012; 59:343–353.
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C.. Hematologic complications of primary immune deficiencies. Blood Rev. 2002; 16:61–64.
   PubMed Web of Science ®Google Scholar